Back to Search Start Over

[Corticosteroids in intensive care medicine].

Authors :
Sensen B
Nierhaus A
Kluge S
Source :
Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 2024 Jun; Vol. 149 (12), pp. 714-718. Date of Electronic Publication: 2024 May 23.
Publication Year :
2024

Abstract

In the case of septic shock, recent studies show benefits from a combination of hydrocortisone and fludrocortisone, but clear guideline recommendations are still lacking. For severe community-acquired pneumonia, early corticosteroid therapy is recommended. Corticosteroid therapy should not be used in influenza-associated community-acquired pneumonia. In contrast, a significantly lower 28-day mortality rate was observed for COVID-19 by the use of dexamethasone. Current guidelines also recommend the use of corticosteroids in Acute Respiratory Distress Syndrome. These recommendations are based primarily on studies that started steroid therapy early. However, many questions such as the type of corticosteroid, the timing and duration of therapy, and the dosage still remain unanswered.<br />Competing Interests: Axel Nierhaus: Biotest AG, Fresenius Medical Care, CytoSorbents Stefan Kluge: Forschungsunterstützung: CytoSorbents, DaiichiSankyo. Vortragstätigkeit: ADVITOS, Biotest, Daiichi Sankyo, Fresenius Medical Care, Gilead, Mitsubishi Tanabe Pharma, MSD, Pfizer, Shionogi, Zoll. Beratertätigkeit: Fresenius, Gilead, MSD, Pfizer.<br /> (Thieme. All rights reserved.)

Details

Language :
German
ISSN :
1439-4413
Volume :
149
Issue :
12
Database :
MEDLINE
Journal :
Deutsche medizinische Wochenschrift (1946)
Publication Type :
Academic Journal
Accession number :
38781995
Full Text :
https://doi.org/10.1055/a-2128-5319